Abstract
The peripheral myelin protein 22 gene (PMP22), the myelin protein zero gene (MPZ, P0), and the connexin 32 gene (Cx32, GJB1) code for membrane proteins expressed in Schwann cells of the peripheral nervous system (PNS). The early growth response 2 gene (EGR2) encodes a transcription factor that may control myelination in the PNS. Mutations in the respective genes, located on human chromosomes 17p11.2, 1q22-q23, Xq13.1, and 10q21.1-q22.1, are associated with several inherited peripheral neuropathies.
To date, a genetic defect in one of these genes has been identified in over 1,000 unrelated patients manifesting a wide range of phenotypes, i.e., Charcot Marie Tooth disease type 1 (CMT1) and type 2 (CMT2), Dejerine-Sottas syndrome (DSS), hereditary neuropathy with liability to pressure palsies (HNPP), and congenital hypomyelination (CH). This large number of genetically defined patients provides an exceptional opportunity to examine the correlation between phenotype and genotype, Hum Mutat 13:11-28, 1999. (C) 1999 Wiley-Liss, Inc.
Original language | English |
---|---|
Pages (from-to) | 11-28 |
Number of pages | 18 |
Journal | Human Mutation |
Volume | 13 |
Publication status | Published - 1999 |
Keywords
- CMT
- HNPP
- DSS
- PMP22
- MPZ
- Cx32
- MARIE-TOOTH-DISEASE
- DEJERINE-SOTTAS DISEASE
- NERVE-CONDUCTION VELOCITIES
- DOMINANT POINT MUTATION
- DE-NOVO DUPLICATION
- PROTEIN ZERO MPZ
- TREMBLER-J MOUSE
- PMP22 GENE
- PO GENE
- HEREDITARY NEUROPATHY